Advanced search
Publication Cover
Leukemia & Lymphoma Volume 19, 1995 - Issue 5-6
Submit an article Journal homepage
22
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Intermittent G-CSF to Maintain Dose Intensity of Chemotherapy for Hodgkin's Disease

Kerrie Clarke Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Victoria, 3050, Australia
&
Andrew Grigg Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Victoria, 3050, Australia
Pages 521-522 | Received 23 Nov 1994, Published online: 01 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vikram K. Chand, Brian K. Link, Justine M. Ritchie, Mary Shannon & James E. Wooldridge. (2006) Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. Leukemia & Lymphoma 47:4, pages 657-663.
Read now

Articles from other publishers (3)

Prahlad Ho, Peter Sherman & Andrew Grigg. (2012) Intermittent granulocyte colony‐stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia. European Journal of Haematology 88:5, pages 416-421.
Crossref
E. Boleti & G.M. Mead. (2007) ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors. Annals of Oncology 18:2, pages 376-380.
Crossref
D.J. Dunlop, M.M. Eatock, J. Paul, S. Anderson, N.S. Reed, M. Soukop, N. Lucie, E.J. Fitzsimmons, P. Tansey & W.P. Steward. (1998) Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. Clinical Oncology 10:2, pages 107-114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.